Upstream Processing

Oct 03, 2016
By BioPharm International Editors
ViraTherapeutics will develop its VSV-GP therapy alone and in combination with other therapies.
Oct 01, 2016
BioPharm International
A new virus-retentive membrane may be used to filter chemical-defined cell culture media for risk mitigation.
Oct 01, 2016
BioPharm International
High-purity low-endotoxin sugars improve robustness and stability of protein formulation and improve drug product quality.
Sep 19, 2016
By BioPharm International Editors
GE Healthcare’s GE BioPark Cork will hold four KUBio manufacturing facilities; GE will also collaborate with NIBRT for biopharmaceutical training.
Sep 01, 2016
By BioPharm International Editors
The platform combines an expression system with equipment and process controls to enable rapid development and scale-up of robust titers.
Sep 01, 2016
BioPharm International
Model effectiveness is determined by the quality and composition of the data inputs.
Sep 01, 2016
BioPharm International
Advances in cell culture media technology have helped achieve safer biologics.
Sep 01, 2016
BioPharm International
The authors outline cell-line development and process scale-up for an antibody program in which the antibody requires additional processing by a site-specific enzyme for correct functionality.
Aug 15, 2016
By BioPharm International Editors
Jacobs Engineering will provide engineering and construction services to expand the Novartis site in Huningue, France.
Aug 15, 2016
By BioPharm International Editors
Irvine Scientific’s new product range includes chemically-defined, serum-free media, to increase productivity of viral vectors and recombinant proteins in suspension cultures.
native1_300x100
lorem ipsum